GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (OTCPK:NTBLQ) » Definitions » Current Ratio

NTBLQ (Notable Labs) Current Ratio : 2.77 (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Notable Labs's current ratio for the quarter that ended in Jun. 2024 was 2.77.

Notable Labs has a current ratio of 2.77. It generally indicates good short-term financial strength.

The historical rank and industry rank for Notable Labs's Current Ratio or its related term are showing as below:

NTBLQ' s Current Ratio Range Over the Past 10 Years
Min: 1.48   Med: 2.77   Max: 5.65
Current: 2.77

During the past 3 years, Notable Labs's highest Current Ratio was 5.65. The lowest was 1.48. And the median was 2.77.

NTBLQ's Current Ratio is ranked worse than
59.41% of 1503 companies
in the Biotechnology industry
Industry Median: 3.69 vs NTBLQ: 2.77

Notable Labs Current Ratio Historical Data

The historical data trend for Notable Labs's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Current Ratio Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Current Ratio
2.17 1.48 5.65

Notable Labs Quarterly Data
Dec21 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
Current Ratio Get a 7-Day Free Trial - - 5.65 4.66 2.77

Competitive Comparison of Notable Labs's Current Ratio

For the Biotechnology subindustry, Notable Labs's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Notable Labs's Current Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's Current Ratio distribution charts can be found below:

* The bar in red indicates where Notable Labs's Current Ratio falls into.



Notable Labs Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Notable Labs's Current Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Current Ratio (A: Dec. 2023 )=Total Current Assets (A: Dec. 2023 )/Total Current Liabilities (A: Dec. 2023 )
=15.47/2.738
=5.65

Notable Labs's Current Ratio for the quarter that ended in Jun. 2024 is calculated as

Current Ratio (Q: Jun. 2024 )=Total Current Assets (Q: Jun. 2024 )/Total Current Liabilities (Q: Jun. 2024 )
=6.984/2.517
=2.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Notable Labs  (OTCPK:NTBLQ) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Notable Labs Current Ratio Related Terms

Thank you for viewing the detailed overview of Notable Labs's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Notable Labs Business Description

Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.